Koen Sandra
Koen Sandra is CEO, RIC, Kortrijk, Belgium.
False
Daddy, What's the Big Deal with Antibodies?
July 31, 2020
The (bio)pharma industry is booming, and so is our role in its success
1 min read
The Coming of Age of 2D-LC
July 3, 2019
Is it time for multidimensional liquid chromatography to step into the spotlight?
1 min read
Top 40 Under 40: 4 Years On
July 4, 2018
With a new Top 40 Under 40 Power List released this year, we catch up with some of the finalists from the last Top 40 to find out where they are now, and how the experience has influenced their career.
1 min read
Specialist Snapshot: Biopharmaceutical Analysis
March 8, 2018
Three analytical experts tell us how biopharmaceutical characterization is evolving to meet the needs of the industry – and vice versa.
1 min read
Landmark Literature: Part II
January 11, 2018
As a new year begins, we turn to 2017 for inspiration, asking experts from across analytical science to select one paper that stood out from the crowd.
1 min read
Quo Vadis, Capillary Gas Chromatography?
January 25, 2017
How mature is capillary gas chromatography (CGC)? Are we close to the maximum achievable for daily routine analyses? Can we reduce or even stop research into CGC technology? Here, we offer personal opinions based on 30 years of service to the industry.
1 min read
The Multidimensional Future of Proteomics
May 23, 2016
The proteome is practically infinite in its complexity. If we are ever going to fully unravel its secrets, the best separation tools – and the best know-how – must be combined. Here, four experts discuss the broad importance of proteomics, the potential of multidimensional liquid chromatography, and the challenges inherent in gaining insight beyond the “tip of the proteo-berg.”
1 min read
Two-dimensional Bioanalysis
May 27, 2014
Bringing biopharmaceuticals and biosimilars to market with 2D-LC
1 min read
Newsletters
Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.
